ADIL

Adial Pharmaceuticals (ADIL)

Adial Pharmaceuticals Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:ADIL

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/15	21:30	GlobeNewswire Inc.	Adial Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update	NASDAQ:ADIL	Adial Pharmaceuticals Inc
2024/05/15	06:03	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:ADIL	Adial Pharmaceuticals Inc
2024/04/22	21:30	GlobeNewswire Inc.	Adial Pharmaceuticals Granted Key Patent from the United States Patent and Trademark Office	NASDAQ:ADIL	Adial Pharmaceuticals Inc
2024/04/10	21:30	GlobeNewswire Inc.	Adial Pharmaceuticals Announces Peer-Reviewed Publication Highlighting Promising Safety Data and High Patient Compliance in a Clinical Trial of AD04 as a Potential Treatment for Alcohol Use Disorder	NASDAQ:ADIL	Adial Pharmaceuticals Inc
2024/04/02	21:30	GlobeNewswire Inc.	Adial Pharmaceuticals Reports 2023 Fiscal Year Financial Results and Provides Business Update	NASDAQ:ADIL	Adial Pharmaceuticals Inc
2024/03/02	09:00	GlobeNewswire Inc.	Adial Pharmaceuticals Announces Exercise of Warrants for $3.5 Million Gross Proceeds	NASDAQ:ADIL	Adial Pharmaceuticals Inc
2024/02/28	23:30	GlobeNewswire Inc.	Adial Pharmaceuticals Awarded New Patent from the United States Patent and Trademark Office	NASDAQ:ADIL	Adial Pharmaceuticals Inc
2024/02/15	05:22	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:ADIL	Adial Pharmaceuticals Inc
2024/02/13	23:15	GlobeNewswire Inc.	Adial Pharmaceuticals Awarded New Patent Notice of Allowance from the United States Patent and Trademark Office	NASDAQ:ADIL	Adial Pharmaceuticals Inc
2024/01/26	06:30	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:ADIL	Adial Pharmaceuticals Inc
2024/01/25	14:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:ADIL	Adial Pharmaceuticals Inc
2024/01/19	06:15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ADIL	Adial Pharmaceuticals Inc
2024/01/18	22:30	GlobeNewswire Inc.	Adial Announces Appointment of Tony Goodman as Chief Operating Officer	NASDAQ:ADIL	Adial Pharmaceuticals Inc
2024/01/17	06:17	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ADIL	Adial Pharmaceuticals Inc
2024/01/13	06:51	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:ADIL	Adial Pharmaceuticals Inc
2023/12/20	23:00	GlobeNewswire Inc.	Adial Pharmaceuticals Receives Final Reimbursement Payment from Adovate	NASDAQ:ADIL	Adial Pharmaceuticals Inc
2023/12/13	06:36	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:ADIL	Adial Pharmaceuticals Inc
2023/12/09	01:08	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:ADIL	Adial Pharmaceuticals Inc
2023/11/30	06:47	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ADIL	Adial Pharmaceuticals Inc
2023/11/30	06:05	GlobeNewswire Inc.	Adial Pharmaceuticals Regains Compliance with Nasdaq Listing Requirement	NASDAQ:ADIL	Adial Pharmaceuticals Inc
2023/11/29	06:10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ADIL	Adial Pharmaceuticals Inc
2023/11/24	23:24	Edgar (US Regulatory)	Form PRE 14A - Other preliminary proxy statements	NASDAQ:ADIL	Adial Pharmaceuticals Inc
2023/11/20	21:46	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:ADIL	Adial Pharmaceuticals Inc
2023/11/20	14:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:ADIL	Adial Pharmaceuticals Inc
2023/11/15	07:02	GlobeNewswire Inc.	Adial Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Business Update	NASDAQ:ADIL	Adial Pharmaceuticals Inc
2023/11/09	06:05	Edgar (US Regulatory)	Form S-1 - General form for registration of securities under the Securities Act of 1933	NASDAQ:ADIL	Adial Pharmaceuticals Inc
2023/11/06	20:14	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ADIL	Adial Pharmaceuticals Inc
2023/10/31	21:30	GlobeNewswire Inc.	Adial Pharmaceuticals Chief Medical Officer and Key Opinion Leaders to Discuss “New Aspects in Substance Use Treatment” at The Annual International Society of Addiction Medicine Conference	NASDAQ:ADIL	Adial Pharmaceuticals Inc
2023/10/31	06:24	Edgar (US Regulatory)	Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]	NASDAQ:ADIL	Adial Pharmaceuticals Inc
2023/10/31	06:18	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	NASDAQ:ADIL	Adial Pharmaceuticals Inc